{
  "ticker": "HPC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968312",
  "id": "02968312",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250710",
  "time": "1659",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250710/pdf/06lpdg62plm9b0.pdf",
  "summary": "### **Substantial Holding Notice \u2013 The Hydration Pharmaceuticals Company Limited (HPC)**  \n\n#### **Material Information Summary:**  \n- **Substantial Holder:** Regal Funds Management Pty Limited and its associates (including Regal Partners Limited).  \n- **Current Holding:** 30,072,908 ordinary shares (8.13% voting power).  \n- **Previous Holding:** 29,124,128 ordinary shares (6.84% voting power).  \n- **Change Trigger:** Dilution due to issuance of **39.5 million new shares** by HPC on **8 July 2025**.  \n- **Recent Transaction (7 April 2025):** Sale of 948,780 shares at **$9,487.80** consideration.  \n\n#### **Key Impact:**  \n- **Dilution Effect:** Significant increase in issued shares (~9.3%) reduces Regal\u2019s stake, signaling possible capital raising by HPC.  \n- **Trading Signal:** Monitor for liquidity changes or further capital actions.  \n\n**No other material disclosures identified.**  \n\n*(Note: Legal/associate details omitted per brevity rules.)*",
  "usage": {
    "prompt_tokens": 1315,
    "completion_tokens": 235,
    "total_tokens": 1550,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-10T07:30:39.209460"
}